GT Biopharma Inc. (GTBP)

AI Score

Unlock

2.27

0.02 (0.89%)

At close: Apr 17, 2025, 3:59 PM

2.33

2.42%

After-hours: Apr 17, 2025, 04:05 PM EDT

GT Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-3.77M	-3.41M	-3.71M	-2.27M	-2.96M	-2.42M	-1.99M	-227K	-5.58M	-6.88M	-2.98M	-5.44M	-18.02M	-5.45M	-4.86M	-29.68M	-14.93M	-2.88M	-8.78M	-1.71M	-1.47M	-29.88M	-2.79M	-4.51M	-4.23M	-235.78M	-9.08M	-10.09M	-6.03M	-132.08M	-2.83M	-2.31M	-2.83M	-3.63M	1.54M	25.95M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	317K	n/a	n/a	n/a	-6K	n/a	9K	1K	2K	3K	1K	1K	n/a	1K	n/a	1K	1K	1K	n/a	n/a
Stock-Based Compensation	8K	n/a	120K	102K	387K	500K	398K	822K	1.33M	2.9M	463K	447K	8.02M	901K	904K	24.1M	-58K	180K	147K	n/a	-894K	2.5M	1.14M	2.56M	1.5M	1.7M	3.43M	3.06M	4.22M	124.38M	651K	873K	779K	1.76M	927K	3.12M
Other Working Capital	1.28M	-231K	31K	-22K	-149K	-379K	-38K	29K	35K	109K	207K	-285K	-105K	-23K	19K	972K	1.87M	981K	-1.1M	1.49M	-1.32M	1.07M	-786K	3K	55K	-27	n/a	n/a	n/a	591K	n/a	n/a	-470K	n/a	n/a	n/a
Other Non-Cash Items	16K	-93K	-93K	819K	106K	-805K	-1.25M	-3.29M	-57K	-11K	24K	29K	-139K	-502K	480K	699K	11.64M	14K	6.32M	784.00	54K	25.18M	1.31M	163K	1.29M	1.63M	7M	266K	123K	1.45M	1.03M	-546K	1.5M	193K	-4.07M	-30.22M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	66K	n/a	n/a	n/a	n/a	n/a	31K	n/a	1K	228.51M	-3.07M	3.07M	n/a	3.42M	n/a	814K	-1K	217K	n/a	n/a
Change in Working Capital	1.28M	767K	147K	-1.37M	376K	395K	1.04M	-40K	13K	-170K	-684K	-1.12M	6.43M	1.13M	-811K	1.19M	1.04M	981K	-1.1M	1.49M	1.83M	1.07M	-786K	820K	191K	501K	-47K	-534K	-468K	591K	759K	523K	410K	895K	532K	976K
Operating Cash Flow	-2.47M	-2.74M	-3.54M	-4.16M	-2.05M	-1.96M	-1.94M	-2.91M	-4.3M	-2.92M	-2.79M	-5.21M	-3.71M	-3.93M	-4.29M	-3.68M	-1.93M	-1.7M	-3.41M	-223K	-485K	-1.13M	-1.09M	-961K	-1.24M	-3.43M	-1.77M	-4.23M	-2.15M	-2.24M	-391K	-650K	-135K	-563K	-1.06M	-167K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-32K	-2K	n/a	-2K	-4	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	5.03M	478K	1.84M	2.66M	-6.99M	n/a	n/a	n/a	n/a	2.99M	-26.03M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	5.03M	n/a	n/a	n/a	n/a	n/a	25K	1.08M	3.53M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	1K	-1K	7.86M	5.03M	478.00	1.84K	2.66K	-6.99K	7.51M	25.00	1.08K	3.53K	2.99K	-26.03K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	200K	n/a	n/a	-36K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1K	n/a	n/a	n/a
Investing Cash Flow	1K	-1K	7.86M	5.03M	478K	1.84M	2.66M	-6.99M	7.51M	25K	1.08M	3.53M	2.99M	-26.03M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	200K	n/a	n/a	-32K	-2K	n/a	-2K	-4	n/a	n/a	n/a	-1K	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.21M	n/a	1.2M	4.26M	200K	200K	975K	1.3M	952K	104K	3.57M	n/a	7.05M	n/a	4.93M	195K	866K	n/a	362K	1.39M	150K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1K	n/a	-223K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	82K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	137K	16.24M	58K	6.87M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-533K	n/a	n/a	n/a	n/a	1.95M	n/a	n/a	n/a
Financial Cash Flow	n/a	n/a	2.98M	n/a	-400K	n/a	n/a	6.27M	-1K	n/a	-223K	n/a	n/a	137K	16.24M	25.94M	6.87M	1.2M	4.26M	200K	200K	975K	1.3M	952K	104K	3.57M	n/a	6.52M	n/a	4.93M	195K	866K	1.95M	362K	1.39M	150K
Net Cash Flow	-2.47M	-2.74M	729K	871K	-1.57M	-119K	722K	-3.63M	3.21M	-2.89M	-1.93M	-1.68M	-714K	-29.82M	11.95M	22.26M	4.95M	-501K	846K	-23K	-285K	49K	213K	-9K	-1.17M	136K	-1.77M	2.29M	-2.16M	2.69M	-196K	216K	-135K	-201K	325K	-17K
Free Cash Flow	-2.47M	-2.74M	-3.54M	-4.16M	-2.05M	-1.96M	-1.94M	-2.91M	-4.3M	-2.92M	-2.79M	-5.21M	-3.71M	-3.93M	-4.29M	-3.68M	-1.93M	-1.7M	-3.41M	-223K	-485K	-1.13M	-1.09M	-961K	-1.28M	-3.44M	-1.77M	-4.23M	-2.15M	-2.24M	-391K	-650K	-135K	-563K	-1.06M	-167K